Business mix
- The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection.
- It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw.
- BillionToOne, Inc. was incorporated in 2016 and is headquartered in Menlo Park, California.
Current key questions
- Can the company's products, services, or pipeline expand adoption within diagnostics & research?
- How do reimbursement, regulation, clinical data, patents, and commercial execution affect growth?
- Can margins and cash flow improve while funding research, manufacturing, or go-to-market investment?
